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Purpose: To investigate the paired box gene 6 (PAX6) in three patients from southern China presenting with classic
aniridia: two patients from two successive generations of one family and one sporadic patient.
Methods: All the available members from two successive generations of one family and one sporadic patient underwent
complete physical and ophthalmic examinations. Genomic DNA was extracted from leukocytes of peripheral blood
collected from the two generations of family members, the sporadic patient and 100 unrelated control subjects from the
same population. Exons 1–13 of the PAX6 gene were amplified by polymerase chain reaction (PCR) and sequenced
directly. The ophthalmic examinations included best-corrected visual acuity, slit-lamp examination, fundus examination,
optical coherence tomography, and Pentacam and Goldmann perimetry.
Results: The three patients were affected with aniridia accompanied by microcornea, microphthalmia, and nystagmus. A
heterozygous PAX6 frameshift mutation, c.891del A(p.Gln297HisfsX68) in exon 10, was identified in the affected
individuals and not in any of the unaffected family members, including the unaffected family members of the proband
patient’s generation. One novel mutation, c.607C>T(Arg203X) in exon 8, was detected in the unrelated sporadic patient.
Conclusions: Although PAX6 gene mutations and polymorphisms have been reported from various ethnic groups, we
report for the first time the identification of two new PAX6 gene mutations in Chinese aniridia patients.
Congenital aniridia is a rare ocular disease that affects the
development of multiple ocular structures; this abnormality is
usually caused by mutations in the paired box gene 6 (PAX6)
located  on  chromosome  11p13  [1-5].  The  disease  is
characterized by a lack of iris and accompanied by other
symptoms, including severe age-related corneal degeneration,
cataract, and nystagmus [6-10].
At present, the PAX6 mutation database lists more than
300 different mutations of that gene [3,11-17]. This study
analyzes the coding sequences of PAX6 in two patients with
aniridia from successive generations of one Chinese family
and one sporadic patient with aniridia. Two novel mutations
in  PAX6  were  detected  in  the  Chinese  population;  both
mutations were heterozygous.
METHODS
The aniridia family: One family (Figure 1) and one sporadic
patient were diagnosed at the Zhongshan Ophthalmic Center
as having aniridia.
We performed the ophthalmic examinations as follows:
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● Visual acuity was examined using the ETDRS
chart (Precision Vision, La Salle, IL).
Figure 1. The pedigree of Chinese Family 1 with aniridia. Square
symbols  denote  males  and  circle  symbols  denote  females.  The
shaded  symbols  indicate  individuals  with  ophthalmologist-
confirmed aniridia. The arrow points to the proband.
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3116● Anterior segment photograph was obtained using
a BX 900 Slit Lamp (Haag-Streit, Bern, Switzerland).
●  A  fundus  photograph  was  obtained  using  a
Heidelberg Retina Angiograph (Heidelberg Engineering,
Heidelberg, Germany).
●  Optical  coherence  tomography  (OCT)  scans
(TOPCON,  Tokyo,  Japan)  were  used  to  assess  the
thickness and pathology of the posterior pole of the retina.
● Anterior segment dimensions were measured with
Pentacam  HR  version  70700  (Oculus,  Weltzar,
Germany).
In  addition,  we  performed  complete  physical
examinations of the patients to exclude systemic diseases.
Sample collection: The two generations of one affected family
and one sporadic patient were identified at the Zhongshan
Ophthalmic Center. One hundred subjects (25.34±8.63 years
old, 45 male) from the same population without diagnostic
features of aniridia were recruited to serve as normal controls.
After  obtaining  informed  consent  from  all  participating
individuals  following  the  principles  of  the  Declaration  of
Helsinki, peripheral venous blood samples were collected for
genomic DNA extraction from the blood leucocytes using
standard protocols.
Detection of the mutation: All coding exons of the known
candidate  gene  (PAX6)  and  their  flanking  regions  were
amplified  by  polymerase  chain  reaction  (PCR)  using  the
primers in Table 1 [18]. Briefly, PCR was conducted in 50
μl reactions and cycling profile included one cycle of 94 °C
for 5 min followed by 40 cycles of 94 °C for 45 s, 52-66 °C
(please  see  Table  1  for  annealing  temperature  and  other
details) for 45 s, and 72 °C for 45 s, and one cycle of 72 °C
for 10 min. The PCR products were sequenced from both
directions  with  the  ABI3730  Automated  Sequencer  (PE
Biosystems, Foster City, CA). The sequencing results were
analyzed using Chromas (version 2.3; Technelysium Pty Ltd,
Brisbane,  Australia)  and  compared  with  the  reference
sequences  in  the  database  at  the  National  Center  for
Biotechnology  Information  (NCBI;  NC_000011.9).  The
superimposed  mutant  PCR  products  were  sub-cloned  into
pGEM-T vector (Promega, Madison, WI) and sequenced to
identify the mutation. Briefly, PCR products were purified by
gel extraction using gel extraction kits (AXYGEN, China)
according  to  the  manufacturer's  instructions.  The  purified
PCR fragments were ligated into the pGEM-T easy vector
(Invitrogen) and the resulting plasmids were transfected by
heat  shock  into  DH5a  competent  Escherichia  coli  for
propagation.  Glycerol  stocks  were  frozen  to  maintain  the
clones. Colonies were picked and grown overnight in 1-2 ml
of  Luria-Bertani  broth  containing  ampicillin  (50  mg/ml).
Plasmids  were  purified  using  the  DNeasy  Miniprep  kit
(Qiagen, China). The plasmid DNA was sequenced using the
ABI3700  and  the  T7  primer.  Sequences  were  determined
using the DNAman software analysis system.
RESULTS
Clinical data: The two generations of the Chinese family and
another  sporadic  patient  (case  3)  studied  in  this  report
originated from the southern area of China. Two individuals
in two successive generations (case I.1 and case II.2) and case
3 were found to have the same congenital ocular disease
(Figure 2).
The  three  patients  had  aniridia  and  bilateral  corneal
degeneration, neovasculation, eyeball horizontal tremor, and
microphthalmia. They showed abnormal vision even from
their early childhood. When this study was performed, the
patients could detect only hand movement.
Applanation  tonometry  revealed  normal  intraocular
pressures in both eyes. Corneas were unnormal in size and
transparency. The width of the cornea of patient II-2 (8 years
old,  female)  was  9.5  mm  (OD)  and  10.0  mm  (OS).The
refractive error of patient II-2 was −1.25 diopters (D; OD) and
−2.25 D (OS). The axial length of the eyes of patient II-2 was
22.82 mm (OD) and 22.84 mm (OS). No abnormalities were
detected in the lens and retina, choroids, and optic nerve. The
anterior segment photograph is shown in Figure 3; the anterior
chamber depth was 1.77 mm (OD) and 1.84 mm (OS).
The width of the cornea for the case 3 patient (5 years old,
male) was 8.5 mm (OD) and 9 mm (OS).The refractive error
TABLE 1. PRIMERS USED FOR PCR.
Exon Forward (5′-3′) Reverse (5′-3′) Product size
(bp)
Annealing
temperature (°C)
4 TGCAGCTGCCCGAGGATTA GCACCCCGAGCCCGAAGTC 144 66
5 TCCCTCTTCTTCCTCTTCACT GGGGTCCATAATTAGCATC 301 58
5 a,6 GCTCTCTACAGTAAGTTCTC AGGAGAGAGCATTGGGCTTA 457 59
7 AATCCACCCACTGTCCCG CCAGCCACCTTCATACCG 542 60
8 TCAGGTAACTAACATCGCA GTTGACTGTACTTGGAAGAA 719 53
9,10,11 GAGGTGGGAACCAGTTTGATG CAAGCCAATCTCTGTAGTGCG 890 52
12 GCTGTGTGATGTGTTCCTCA AAGAGAGATCGCCTCTGTG 245 58
13 CATGTCTGTTTCTCAAAGGG CCATAGTCACTGACTGAATTAACAC 202 58
               Summary of the primers and product length used for the amplification of PAX6 exons.
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3117of the case 3 was +4.50 D (OD) and +6.00 D (OS). The axial
length of the eyeballs in case 3 was 19.90 mm (OD) and
19.70 mm (OS). No abnormalities were detected in the lens
and retina, choroids, and optic nerve. The anterior chamber
depth was 1.89 mm (OD) and 1.99 mm (OS).
Mutation  screening:  In  the  two  affected  cases  within  the
families,  a  heterozygous  A  deletion  at  nucleotide  891  (c.
891delA) in exon 10 of PAX6 was confirmed by sequencing
(Figure 4A). This frameshift mutation is predicted to cause a
premature termination codon (PTC) 68 codons downstream
from the ﬁrst new inappropriate codon 297 created by the
nucleotide deletion (p.Gln297HisfsX68).
One novel mutation c.607C>T(Arg203X) in exon 8 was
detected in the sporadic patient (Figure 4B). No mutations
were  found  in  any  of  the  unaffected  family  members,
including the unaffected members of the patient’s generation.
DISCUSSION
In this study, we found two mutations, one in each of the two
exons of PAX6 that are associated with aniridia: c.891delA
and  c.607C>T.  These  two  mutations,  rather  than  a  rare
polymorphism in the normal population, are the causative
mutations in the family and the sporadic patient, respectively.
The  novel  characteristic  of  the  c.891delA  mutation
identiﬁed in PAX6 of the family members in the present study
is that it occurred at a non-hotspot for mutations. The location
is consistent with this mutation’s presence for the ﬁrst time in
PAX6 of Chinese patients.
Figure 2. Ocular photographs of patient II-2 (A) and the sporadic patient 3 (B) with aniridia. The two patients each had aniridia and bilateral
corneal degeneration, neovasculation, eyeball horizontal tremor, and microphthalmia.
Figure 3. Pentacam photo showing the anterior segment picture of patientII-2.
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than 10 unrelated aniridia patients [19], but this is the first
mutation  reported  in  two  generations  of  related  Chinese
patients. Both mutations are among the most common base
changes found in PAX6.
The affected members from the family and the sporadic
patient had almost the same phenotypes, but different novel
mutations. Different phenotypes caused by the same PAX6
mutation  have  also  been  reported  previously  [20].  These
anomalies  complicate  analyzing  the  correlation  between
genotypes and phenotypes [21,22].
In summary, this study identified two novel mutations of
PAX6 in a Chinese family and a sporadic patient with aniridia.
This finding expands the mutation spectrum of PAX6 and is
useful  and  valuable  for  genetic  counseling  and  prenatal
diagnosis in families where aniridia appears, accompanied by
corneal  degeneration,  neovasculation,  eyeball  horizontal
tremor, and microphthalmia.
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